- Report
- August 2023
- 80 Pages
Germany
From €666EUR$750USD£573GBP
€1331EUR$1,500USD£1,146GBP
- Report
- August 2023
- 80 Pages
France
From €666EUR$750USD£573GBP
€1331EUR$1,500USD£1,146GBP
- Report
- August 2023
- 80 Pages
China
From €666EUR$750USD£573GBP
€1331EUR$1,500USD£1,146GBP
- Report
- August 2023
- 300 Pages
Global
From €1110EUR$1,250USD£955GBP
€2219EUR$2,500USD£1,910GBP
- Report
- January 2024
- 150 Pages
Global
From €3417EUR$3,850USD£2,941GBP
€4305EUR$4,850USD£3,705GBP
- Report
- July 2024
- 171 Pages
Global
From €3994EUR$4,500USD£3,438GBP
- Report
- May 2022
- 109 Pages
Middle East, Africa
From €1331EUR$1,500USD£1,146GBP
- Report
- October 2024
- 70 Pages
China
From €843EUR$950USD£726GBP
- Report
- October 2024
- 70 Pages
France
From €843EUR$950USD£726GBP
- Report
- October 2024
- 70 Pages
Germany
From €843EUR$950USD£726GBP
- Report
- October 2024
- 70 Pages
India
From €843EUR$950USD£726GBP
- Report
- October 2024
- 70 Pages
United Kingdom
From €843EUR$950USD£726GBP
- Report
- June 2025
- 77 Pages
Japan
From €2175EUR$2,450USD£1,872GBP
- Report
- October 2023
- 85 Pages
United States
From €4305EUR$4,850USD£3,705GBP
- Report
- July 2023
- 225 Pages
Global
From €3994EUR$4,500USD£3,438GBP
- Report
- June 2020
- 464 Pages
Global
From €4349EUR$4,900USD£3,743GBP
- Report
- August 2023
- 80 Pages
Russia
From €666EUR$750USD£573GBP
€1331EUR$1,500USD£1,146GBP
- Report
- August 2023
- 80 Pages
Poland
From €666EUR$750USD£573GBP
€1331EUR$1,500USD£1,146GBP
- Report
- August 2023
- 100 Pages
Africa
From €888EUR$1,000USD£764GBP
€1775EUR$2,000USD£1,528GBP
- Report
- August 2024
- 107 Pages
Global
From €3500EUR$4,224USD£3,118GBP

The genotyping market is a subset of the genomics industry that focuses on the identification of genetic variations between individuals. It is used to identify genetic markers associated with diseases, to determine the risk of developing certain conditions, and to identify the most effective treatments for a given individual. Genotyping is also used in the development of personalized medicine, which is tailored to the individual’s genetic makeup. Genotyping technologies include next-generation sequencing, microarrays, and PCR-based methods.
The genotyping market is expected to grow due to the increasing demand for personalized medicine, the development of new technologies, and the increasing availability of genomic data. Additionally, the increasing prevalence of chronic diseases and the need for more accurate diagnosis and treatment are expected to drive the growth of the genotyping market.
Some companies in the genotyping market include Illumina, Thermo Fisher Scientific, BGI, Agilent Technologies, and PerkinElmer. Show Less Read more